You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 251 No. 16, April 27, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Prevention of uterine perforation during curettage abortion

D. A. Grimes, K. F. Schulz and W. J. Cates Jr

Although uterine perforation is a potentially life-threatening complication of curettage abortion, little is known about the risk factors associated with uterine perforation or how to prevent it. Using linear logistic regression, we analyzed 67,175 curettage abortions performed at 13 institutions in the United States from 1975 through 1978. The overall incidence of confirmed perforation was 0.9 per 1,000 abortions. Performance of the abortion by a resident rather than by an attending physician was a powerful risk factor for perforation (relative risk, 5.5; 95% confidence interval, 3.3 to 9.2). Use of Laminaria for dilation had a protective effect, although this effect was not statistically significant (relative risk, 0.17; 95% confidence interval, 0.02 to 1.2). Among factors beyond the control of the physician, advancement of gestational age and previous delivery were significant risk factors. Use of Laminaria and performance of the abortion by an attending physician considerably lowered the risk of uterine perforation.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mid-trimester induced abortion: a review
Lalitkumar et al.
Hum Reprod Update 2007;13:37-52.
ABSTRACT | FULL TEXT  

Misoprostol Compared With Laminaria Before Early Second-Trimester Surgical Abortion: A Randomized Trial
Goldberg et al.
Obstet Gynecol 2005;106:234-241.
ABSTRACT | FULL TEXT  

A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester
Tang et al.
Hum Reprod 2004;19:1101-1104.
ABSTRACT | FULL TEXT  

Manual Versus Electric Vacuum Aspiration for Early First-Trimester Abortion: A Controlled Study of Complication Rates
Goldberg et al.
Obstet Gynecol 2004;103:101-107.
ABSTRACT | FULL TEXT  

Gemeprost Versus Misoprostol for Cervical Priming Before First-Trimester Abortion: A Randomized Controlled Trial
Ekerhovd et al.
Obstet Gynecol 2003;101:722-725.
ABSTRACT | FULL TEXT  

Magnetic resonance imaging of the human cervix: a study of the effects of prostaglandins in the first trimester
Rae et al.
Hum Reprod 2001;16:1744-1747.
ABSTRACT | FULL TEXT  

Misoprostol and Pregnancy
Goldberg et al.
NEJM 2001;344:38-47.
FULL TEXT  

Cavitary Lung Disease
King et al.
Chest 2001;119:300-302.
ABSTRACT | FULL TEXT  

Evacuation Interval After Vaginal Misoprostol for Preabortion Cervical Priming: A Randomized Trial
SINGH et al.
Obstet Gynecol 1999;94:431-434.
ABSTRACT | FULL TEXT  

Does an acidic medium enhance the efficacy of vaginal misoprostol for pre-abortion cervical priming?
Singh et al.
Hum Reprod 1999;14:1635-1637.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial of Laminaria, Oral Misoprostol, and Vaginal Misoprostol Before Abortion
MACISAAC et al.
Obstet Gynecol 1999;93:766-770.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.